{"title":"[A Case of Gastric Remnant Cancer with Multiple Liver Metastases Treated with SOX + Nivolumab Therapy and Conversion Surgery].","authors":"Kazuma Horiguchi, Takahiro Tashiro, Daisuke Koike, Masahiro Ito, Hiroyuki Kato, Satoshi Arakawa, Masahiro Shimura, Hironobu Yasuaka, Takahiko Higashiguchi, Yoshiki Kunimura, Hiroki Tani, Yutaro Kato, Tsunekazu Hanai, Akihiko Horiguchi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A male patient in his 60s with a history of distal gastrectomy (Billroth Ⅱ) for duodenal ulcer 40 years ago. Fecal occult blood was positive, and endoscopy revealed a type 3 tumor at the anastomotic site. He was referred to our hospital and diagnosed with remnant gastric cancer and multiple liver metastases (cT4aN1M1, Stage ⅣB). He received 18 courses of SOX + nivolumab chemotherapy. Liver metastases disappeared, but PET-CT showed residual uptake at the primary site. Laparoscopic total remnant gastrectomy with D2 lymph node dissection was performed as a conversion surgery. Pathology showed no residual cancer. Chemotherapy with nivolumab was effective in enabling conversion surgery.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 4","pages":"281-283"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
A male patient in his 60s with a history of distal gastrectomy (Billroth Ⅱ) for duodenal ulcer 40 years ago. Fecal occult blood was positive, and endoscopy revealed a type 3 tumor at the anastomotic site. He was referred to our hospital and diagnosed with remnant gastric cancer and multiple liver metastases (cT4aN1M1, Stage ⅣB). He received 18 courses of SOX + nivolumab chemotherapy. Liver metastases disappeared, but PET-CT showed residual uptake at the primary site. Laparoscopic total remnant gastrectomy with D2 lymph node dissection was performed as a conversion surgery. Pathology showed no residual cancer. Chemotherapy with nivolumab was effective in enabling conversion surgery.